{
  "id": 4735757,
  "title": "Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update",
  "url": "https://urgent.news/2026/08/31/rakovina-therapeutics-announces-q2-2026-financial-results-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-31T23:04:00.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/rakovina-therapeutics-announces-q2-2026-financial-results-and-provides-corporate-update"
  },
  "original_language": "en",
  "account": null,
  "summary": "All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}